Cargando…
Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784573/ https://www.ncbi.nlm.nih.gov/pubmed/35123336 http://dx.doi.org/10.1016/j.schres.2022.01.035 |
_version_ | 1784638769458053120 |
---|---|
author | Prokopez, Cintia R. Farinola, Romina Vallejos, Miguel Lopredo, Lorena S. Sfriso, Luciano E. Chiapella, Luciana C. Arce, Claudio Corral, Ricardo M. Cuesta, Manuel J. Alomo, Martín |
author_facet | Prokopez, Cintia R. Farinola, Romina Vallejos, Miguel Lopredo, Lorena S. Sfriso, Luciano E. Chiapella, Luciana C. Arce, Claudio Corral, Ricardo M. Cuesta, Manuel J. Alomo, Martín |
author_sort | Prokopez, Cintia R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8784573 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87845732022-01-24 Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2? Prokopez, Cintia R. Farinola, Romina Vallejos, Miguel Lopredo, Lorena S. Sfriso, Luciano E. Chiapella, Luciana C. Arce, Claudio Corral, Ricardo M. Cuesta, Manuel J. Alomo, Martín Schizophr Res Letter to the Editor Elsevier B.V. 2022-03 2022-01-24 /pmc/articles/PMC8784573/ /pubmed/35123336 http://dx.doi.org/10.1016/j.schres.2022.01.035 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Prokopez, Cintia R. Farinola, Romina Vallejos, Miguel Lopredo, Lorena S. Sfriso, Luciano E. Chiapella, Luciana C. Arce, Claudio Corral, Ricardo M. Cuesta, Manuel J. Alomo, Martín Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2? |
title | Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2? |
title_full | Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2? |
title_fullStr | Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2? |
title_full_unstemmed | Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2? |
title_short | Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2? |
title_sort | olanzapine, risperidone and quetiapine: do these atypical antipsychotics have a protective effect for sars-cov-2? |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784573/ https://www.ncbi.nlm.nih.gov/pubmed/35123336 http://dx.doi.org/10.1016/j.schres.2022.01.035 |
work_keys_str_mv | AT prokopezcintiar olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2 AT farinolaromina olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2 AT vallejosmiguel olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2 AT lopredolorenas olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2 AT sfrisolucianoe olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2 AT chiapellalucianac olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2 AT arceclaudio olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2 AT corralricardom olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2 AT cuestamanuelj olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2 AT alomomartin olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2 |